Alexion Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Alexion Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Alexion Pharmaceuticals Inc Strategy Report
- Understand Alexion Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Alexion Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
03 Oct 2022 | Alexion, AstraZeneca Rare Disease to Acquire LogicBio Therapeutics | Acquisition |
AstraZeneca Plc
Alexion Pharmaceuticals Inc |
Logicbio Therapeutics Inc
|
07 Jan 2022 | Alexion Pharma Enters into Licensing Agreement with Neurimmune | Licensing Agreement |
Alexion Pharmaceuticals Inc
|
Neurimmune Holding AG
|
29 Sep 2021 | Alexion Pharma Acquires Caelum Biosciences | Acquisition |
Alexion Pharmaceuticals Inc
|
Caelum Biosciences Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer